Insider Transactions in Q2 2023 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Olivier Danos Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,123
+1.17%
|
$17,968
$16.99 P/Share
|
|
Jun 02
2023
|
Jennifer Zachary |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+26.83%
|
-
|
|
Jun 02
2023
|
Jean Bennett |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+34.92%
|
-
|
|
Jun 02
2023
|
Argeris N Karabelas |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+34.92%
|
-
|
|
Jun 02
2023
|
Alexandra Glucksmann |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+34.92%
|
-
|
|
Jun 02
2023
|
George V Migausky |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+34.92%
|
-
|
|
Jun 02
2023
|
David C Stump |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+34.92%
|
-
|
|
Jun 02
2023
|
Daniel Tasse |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+34.92%
|
-
|
|
Jun 02
2023
|
Allan M. Fox |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+34.92%
|
-
|
|
May 31
2023
|
Vittal Vasista Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+14.0%
|
$0
$0.85 P/Share
|